Leishmaniasis emergence in Europe

Eurosurveillance

Volumn 15, Issue 10, 2010, Pages 29-39

  Ready, P D ^a  

^a DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTILEISHMANIAL AGENT; ANTIRETROVIRUS AGENT; BCG VACCINE; MILTEFOSINE; PAROMOMYCIN; RECOMBINANT PROTEIN; SAPONIN DERIVATIVE;

CLIMATE CHANGE; CLINICAL TRIAL (TOPIC); DISEASE RE-EMERGENCE; ENVIRONMENTAL CHANGE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; LEISHMANIA INFANTUM; LEISHMANIASIS; NONHUMAN; PARASITE TRANSMISSION; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SKIN LEISHMANIASIS; SOCIOECONOMICS; VISCERAL LEISHMANIASIS;

EID: 77952520609     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. World Health Organization (WHO). Leishmaniasis: background information. A brief history of the disease. WHO. 2009. Available from: www.who.int/leishmaniasis/en/
2. Ready P.D. Leishmaniasis emergence and climate change. In: S de la Roque, editor. Climate change: the impact on the epidemiology and control of animal diseases. Rev Sci Tech Off Int Epiz. 2008;27(2):399-412.
3. Killick-Kendrick R. Phlebotomine vectors of the leishmaniases: a review. Med Vet Entomol. 1990;4(1):1-24.
4. Peters N, Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev. 2006;213:159-79.
5. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305-18.
6. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95(3):239-43.
7. Trotz-Williams LA, Trees AJ. Systematic review of the distribution of the major vector-borne parasitic infections in dogs and cats in Europe. Vet Rec. 2003;152(4):97-105.
8. Gramiccia M, Gradoni L. The leishmaniases in Southern Europe. In: W Takken, BGJ Knols, editors. Emerging pests and Vector-Borne Diseases, Ecology and control of vectorborne diseases, Vol. 1. Wageningen Academic Publishers. 2007:75-95.
9. World Health Organization (WHO). Regional Office for Europe. Vectorborne and rodentborne diseases. WHO. 29 September 2009. Available from: http://www.euro.who.int/globalchange/Assessment/20070216_10
10. Moral L, Rubio EM, Moya M. A leishmanin skin test survey in the human population of l'Alacantí region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe. Trans R Soc Trop Med Hyg. 2002;96(2):129-32.
11. Martín-Sánchez J, Pineda JA, Morillas-Márquez F, García-García JA, Acedo C, Macías J. Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: relationship between polymerase chain reaction results and other Leishmania infection markers. Am J Trop Med Hyg. 2004;70(5):545-8.
12. Pratlong F, Rioux JA, Marty P, Faraut-Gambarelli F, Dereure J, Lanotte G, et al. Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features. J Clin Microbiol. 2004;42(9):4077-82.
13. Marty P, Izri A, Ozon C, Haas P, Rosenthal E, Del Giudice P, et al. A century of leishmaniasis in Alpes-Maritimes, France. Ann Trop Med Parasitol. 2007;101(7):563-74.
14. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López Vélez R, et al. Leishmania and human immunodeficiency virus co-infection: the first 10 years. Clin Microbiol Rev. 1997;10(2):298-319.
15. Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol. 2003;97 Suppl 1:3-15.
16. Bates PA. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol. 2007;37(10):1097-106.
17. Desjeux P. Information on the epidemiology and control of the leishmaniases by country or territory. WHO/LEISH/91.30. Geneva: World Health Organization. 1991.
18. World Health Organization. Control of the Leishmaniases. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1990;793:1-158.
19. Mauricio IL, Gaunt MW, Stothard JR, Miles MA. Glycoprotein 63 (gp63) genes show gene conversion and reveal the evolution of Old World Leishmania. Int J Parasitol. 2007;37(5):565-76.
20. Maroli M, Pennisi MG, Di Muccio T, Khoury C, Gradoni L, Gramiccia M. Infection of sandflies by a cat naturally infected with Leishmania infantum. Vet Parasitol. 2007;145(3-4):357-60.
21. Solano-Gallego L, Rodríguez-Cortés A, Iniesta L, Quintana J, Pastor J, Espada Y. Cross-sectional serosurvey of feline leishmaniasis in ecoregions around the Northwestern Mediterranean. Am J Trop Med Hyg. 2007;76(4):676-80.
22. Ready P. Sand fly evolution and its relationship to Leishmania transmission. Mem Inst Oswaldo Cruz 2000;95(4):589-90.
23. Cruz I, Morales MA, Noguer I, Rodríquez A, Alvar J. Leishmania in discarded syringes from intravenous drug users. Lancet. 2002;359(9312):1124-5.
24. Duprey ZH, Steurer FJ, Rooney JA, Kirchhoff LV, Jackson JE, Rowton ED, et al. Canine visceral leishmaniasis, United States and Canada, 2000-2003. Emerg Infect Dis. 2006;12(3):440-6.
25. Harms G, Schönian G, Feldmeier H. Leishmaniasis in Germany. Emerg Infect Dis. 2003;9(7):872-5.
26. Naucke TJ, Schmitt C. Is leishmaniasis becoming endemic in Germany? Int J Med Microbiol. 2004;293 Suppl 37:179-81.
27. Mettler M, Grimm F, Naucke TJ, Maasjost C, Deplazes P. [Canine leishmaniosis in Central Europe: retrospective survey and serological study of imported and travelling dogs]. Berl Munch Tierarztl Wochenschr. 2005;118(1-2):37-44. German.
28. Meinecke CK, Schottelius J, Oskam L, Fleischer B. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child. Pediatrics. 1999;104(5):e65.
29. World Organisation for Animal Health (OIE). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. OIE. 2004. Available from: http://www.oie.int/fr/normes/mmanual/a_00050.htm
30. Rioux JA, Lanotte G. Leishmania infantum as a cause of cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1990;84(6):898.
31. Evans D, editor. Handbook on Isolation, Characterization and Cryopreservation of Leishmania. Geneva: World Health Organization; 1989.
32. Lukes J, Mauricio IL, Schönian G, Dujardin JC, Soteriadou K, Dedet JP, et al. Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci USA. 2007;104(22):9375-80.
33. Alvar J, Barker JR. Molecular tools for epidemiological studies and diagnosis of leishmaniasis and selected other parasitic diseases. Trans R Soc Trop Med Hyg. 2002;96:1-250.
34. Schönian G, Mauricio I, Gramiccia M, Cañavate C, Boelaert M, Dujardin JC. Leishmaniases in the Mediterranean in the era of molecular epidemiology. Trends Parasitol. 2008;24(3):135-42.
35. Parvizi P, Mazloumi-Gavgani AS, Davies CR, Courtenay O, Ready PD. Two Leishmania species circulating in the Kaleybar focus of 'infantile visceral leishmaniasis', northwest Iran: implications for deltamethrin dog collar intervention. Trans R Soc Trop Med Hyg. 2008;102(9):891-97.
36. Shaw JJ, De Faria DL, Basano SA, Corbett CE, Rodrigues CJ, Ishikawa EA, et al. The aetiological agents of American cutaneous leishmaniasis in the municipality of Monte Negro, Rondônia state, western Amazonia, Brazil. Ann Trop Med Parasitol. 2007;101(8):681-8.
37. Ardehali S, Moattari A, Hatam GR, Hosseini SM, Sharifi I. Characterization of Leishmania isolated in Iran: 1. Serotyping with species specific monoclonal antibodies. Acta Trop. 2000;75(3):301-7.
38. Boelaert M, El-Safi S, Hailu A, Mukhtar M, Rijal S, Sundar S, et al. Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg. 2008;102(1):32-40.
39. Ameen M. Cutaneous leishmaniasis: therapeutic strategies and future directions. Expert Opin Pharmacother. 2007;8(16):2689-99.
40. Gradoni L, Soteriadou K, Louzir H, Dakkak A, Toz SO, Jaffe C, et al. Drug regimens for visceral leishmaniasis in Mediterranean countries. Trop Med Int Health. 2008;13(10):1272-6.
41. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19(1):111-26.
42. López-Vélez R. The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV. Ann Trop Med Parasitol. 2003;97 Suppl 1:143-7.
43. Rogers ME, Sizova OV, Ferguson MA, Nikolaev AV, Bates PA. Synthetic glycovaccine protects against the bite of Leishmaniainfected sand flies. J Infect Dis. 2006;194(4):512-8.
44. Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, et al. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med. 2001;194(3):331-42.
45. World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases (WHO). Eighteenth Programme Report. Progress 2005-2006. Geneva: WHO. 2007.
46. Reed SG, Campos-Neto A. Vaccines for parasitic and bacterial diseases. Curr Opin Immunol. 2003;15(4):456-60.
47. Nogueira FS, Moreira MA, Borja-Cabrera GP, Santos FN, Menz I, Parra LE, et al. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine. 2005;23(40):4805-10.
48. Parra LE, Borja-Cabrera GP, Santos FN, Souza LO, Palatnik-de-Sousa CB, Menz I. Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil. Vaccine. 2007;25(12):2180-6.
49. Lemesre JL, Holzmuller P, Cavaleyra M, Gonçalves RB, Hottin G, Papierok G. Protection against experimental visceral leishmanisis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine. 2005;23(22):2825-40.
50. Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, et al. Long-lasting protection against canine leishmanisis using LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy trial. Vaccine. 2007;25(21):4223-34.
51. Carson C, Antoniou M, Ruiz-Argüello MB, Alcami A, Christodoulou V, Messaritakis I, et al. A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis. Vaccine. 2009;27(7):1080-6.
52. Centers for Disease Control and Prevention (CDC). Parasitic Disease Information. Leishmania Infection. 2008. Atlanta: CDC. Available from: http://www.cdc.gov/ncidod/dpd/parasites/leishmania/factsht_leishmania.htm#prevent
53. Reithinger R, Teodoro U, Davies CR. Topical insecticide treatments to protect dogs from sand fly vectors of leishmaniasis. Emerg Infect Dis. 2001;7(5):872-6.
54. Killick-Kendrick R, Killick-Kendrick M, Focheux C, Dereure J, Puech MP, Cadiergues MC. Protection of dogs from the bites of phlebotomine sandflies by deltamethrin collars for the control of canine leishmaniasis. Med Vet Entomol. 1997;11(2):105-11.
55. Maroli M, Mizzon V, Siragusa C, D'Oorazi A, Gradoni L. Evidence for an impact on the incidence of canine leishmaniasis by the use of deltamethrin-impregnated dog collars in southern Italy. Med Vet Entomol. 2001;15(4):358-63.
56. Lainson R, Shaw JJ, Silveira FT, de Souza AA, Braga RR, Ishikawa EA. The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia. Mem Inst Oswaldo Cruz. 1994;89(3):435-43.
57. Gállego M, Pratlong F, Fisa R, Riera C, Rioux JA, Dedet JP, et al. The life-cycle of Leishmania infantum MON-77 in the Priorat (Catalonia, Spain) involves humans, dogs and sandflies; also literature review of distribution and hosts of L. infantum zymodemes in the Old World. Trans R Soc Trop Med Hyg. 2001;95(3);269-71.
58. Aransay AM, Testa JM, Morillas-Marquez F, Lucientes J, Ready PD. Distribution of sandfly species in relation to canine leishmaniasis from the Ebro Valley to Valencia, northeastern Spain. Parasitol Res. 2004;94(6):416-20.
59. Houin R, Deniau M, Puel F, Reynouard F, Barbier D, Bonnet M. [ Phlebotomine sandflies of Touraine]. Ann Parasitol Hum Comp. 1975;50(2):233-43. French.
60. Rioux JA, Golvan YJ. [Epidemiology of the leishmaniases in the south of France]. National Institute of Health and Medical Research (INSERM) Monography. Paris. 1969;37:1-223. French.
61. Aransay AM, Ready PD, Morillas-Marquez F. Population differentiation of Phlebotomus perniciosus in Spain following postglacial dispersal. Heredity. 2003;90(4):316-25.
62. Perrotey S, Mahamdallie S, Pesson B, Richardson KJ, Gállego M, Ready PD. Postglacial dispersal of Phlebotomus perniciosus into France. Parasite 2005;12(4):283-91.
63. Rioux JA, de la Roque S. [Climates, leishmaniasis and trypanosomiasis.] In: Rodhain F, editor. [Climate change, infectious and allergic diseases]. Éditions scientifiques et médicales, Elsevier. 2003. 41-62.
64. Martinez S, Vanwambeke SO, Ready P. Linking changes in landscape composition and configuration with sandfly occurrence in southwest France. Fourth International Workshop on the Analysis of Multi-temporal Remote Sensing Images, 2007. MultiTemp 2007.
65. Maroli M, Rossi L, Baldelli R, Capelli G, Ferroglio E, Genchi C, et al. The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors. Trop Med Int Health. 2008;13(2):256-64.
66. Dye C, Guy MW, Elkins DB, Wilkes TJ, Killick-Kendrick R. The life expectancy of phlebotomine sandflies: first field estimates from southern France. Med Vet Entomol. 1987;1(4):417-25.
67. Volf P, Hostomska J, Rohousova I. Molecular crosstalks in Leishmania-sandfly-host relationships. Parasite. 2008;15(3):237-43.
68. Rossi E, Bongiorno G, Ciolli E, Di Muccio T, Scalone A, Gramiccia M, et al. Seasonal phenology, host-blood feeding preferences and natural Leishmania infection of Phlebotomus perniciosus (Diptera, Psychodidae) in a high-endemic focus of canine leishmaniasis in Rome province, Italy. Acta Trop. 2008;105(2):158-65.
69. Depaquit J, Naucke TJ, Schmitt C, Ferte H, Leger N. A molecular analysis of the subgenus Transphlebotomus Artemiev, 1984 (Phlebotomus, Diptera, Psychodidae) inferred from ND4 mtDNA with new northern records of Phlebotomus mascittii Grassi, 1908. Parasitol Res. 2005;95(2):113-6.
70. El Hajj L, Thellier M, Carrière J, Bricaire F, Danis M, Caumes E. Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases. Int J Dermatol. 2004;43(2):120-5.
71. Antinori S, Gianelli E, Calattini S, Longhi E, Gramiccia M, Corbellino M. Cutaneous leishmaniasis: an increasing threat for travellers. Clin Microbiol Infect. 2005;11(5):343-6.
72. Lawn SD, Whetham J, Chiodini PL, Kanagalingam J, Watson J, Behrens RH et al. New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. QJM. 2004;97(12):781-8.
73. Rotureau B, Ravel C, Aznar C, Carme B, Dedet JP. First report of Leishmania infantum in French Guiana: canine visceral leishmaniasis imported from the Old World. J Clin Microbiol. 2006;44(3):1120-2.
74. Antoniou M, Haralambous C, Mazeris A, Pratlong F, Dedet JP, Soteriadou K. Leishmania donovani leishmaniasis in Cyprus. Lancet Infect Dis. 2009;9(2), 76-7.
75. Dye C. The logic of visceral leishmaniasis control. Am J Trop Med Hyg. 1996;55(2):125-30.
76. Magill AJ, Grögl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med. 1993;328(19):1383-7.
77. Crum NF, Aronson NE, Lederman ER, Rusnak JM, Cross JH. History of U.S. military contributions to the study of parasitic diseases. Mil Med. 2005;170(4 Suppl):17-29.
78. Martín-Sánchez J, Morales-Yuste M, Acedo-Sanchez C, Baron S, Diaz V, Morillas-Marquez F. Canine Leishmaniasis in southeastern Spain. Emerg Infect Dis. 2009; 15:795-8.
79. Dujardin JC, Campino L, Cañavate C, Dedet JP, Gradoni L, Soteriadou K, et al. Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis. 2008;14(7):1013-8.
80. LeishRisk [Internet]. Belgium: European Commission. [cited 2009 Mar 16]. Available from: http://www.leishrisk.net/leishrisk/
81. World Organisation for Animal Health (OIE) [Internet]. OIE Listed diseases. France: OIE. [updated 2007 Mar 14; cited 2009 Mar 16]. Available from: www.oie.int/eng/maladies/en_classification2007.htm?e1d7